• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用生物类似物黏液优化用于黏液渗透和纳米颗粒区分的高通量模型

Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus.

作者信息

Wright Leah, Barnes Timothy J, Joyce Paul, Prestidge Clive A

机构信息

UniSA: Clinical and Health Sciences, University of South Australia, Adelaide 5000, Australia.

出版信息

Pharmaceutics. 2022 Nov 30;14(12):2659. doi: 10.3390/pharmaceutics14122659.

DOI:10.3390/pharmaceutics14122659
PMID:36559151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9782027/
Abstract

High-throughput permeation models are essential in drug development for timely screening of new drug and formulation candidates. Nevertheless, many current permeability assays fail to account for the presence of the gastrointestinal mucus layer. In this study, an optimised high-throughput mucus permeation model was developed employing a highly biorelevant mucus mimic. While mucus permeation is primarily conducted in a simple mucin solution, the complex chemistry, nanostructure and rheology of mucus is more accurately modelled by a synthetic biosimilar mucus (BSM) employing additional protein, lipid and rheology-modifying polymer components. Utilising BSM, equivalent permeation of various molecular weight fluorescein isothiocyanate-dextrans were observed, compared with native porcine jejunal mucus, confirming replication of the natural mucus permeation barrier. Furthermore, utilising synthetic BSM facilitated the analysis of free protein permeation which could not be quantified in native mucus due to concurrent proteolytic degradation. Additionally, BSM could differentiate between the permeation of poly (lactic-co-glycolic) acid nanoparticles (PLGA-NP) with varying surface chemistries (cationic, anionic and PEGylated), PEG coating density and size, which could not be achieved by a 5% mucin solution. This work confirms the importance of utilising highly biorelevant mucus mimics in permeation studies, and further development will provide an optimal method for high-throughput mucus permeation analysis.

摘要

高通量渗透模型在药物开发中对于及时筛选新的药物和制剂候选物至关重要。然而,目前许多渗透性测定未能考虑胃肠道黏液层的存在。在本研究中,采用高度生物相关的黏液模拟物开发了一种优化的高通量黏液渗透模型。虽然黏液渗透主要在简单的黏蛋白溶液中进行,但通过使用额外的蛋白质、脂质和流变学改性聚合物成分的合成生物相似黏液(BSM)可以更准确地模拟黏液的复杂化学、纳米结构和流变学。利用BSM,观察到与天然猪空肠黏液相比,各种分子量的异硫氰酸荧光素 - 葡聚糖具有等效的渗透性,证实了天然黏液渗透屏障的复制。此外,利用合成BSM有助于分析游离蛋白质的渗透,由于同时存在的蛋白水解降解,在天然黏液中无法对其进行定量。此外,BSM可以区分具有不同表面化学性质(阳离子、阴离子和聚乙二醇化)、聚乙二醇涂层密度和尺寸的聚(乳酸 - 乙醇酸)纳米颗粒(PLGA - NP)的渗透,而5%的黏蛋白溶液无法做到这一点。这项工作证实了在渗透研究中使用高度生物相关的黏液模拟物的重要性,进一步的发展将为高通量黏液渗透分析提供一种优化方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/5ef74fc8c537/pharmaceutics-14-02659-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/8c90e318c2ea/pharmaceutics-14-02659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/3204fd1fe1c1/pharmaceutics-14-02659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/f6f9341435b2/pharmaceutics-14-02659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/d2bfb834a45c/pharmaceutics-14-02659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/8455bcea5a4e/pharmaceutics-14-02659-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/303b7e87e05f/pharmaceutics-14-02659-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/5ef74fc8c537/pharmaceutics-14-02659-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/8c90e318c2ea/pharmaceutics-14-02659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/3204fd1fe1c1/pharmaceutics-14-02659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/f6f9341435b2/pharmaceutics-14-02659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/d2bfb834a45c/pharmaceutics-14-02659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/8455bcea5a4e/pharmaceutics-14-02659-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/303b7e87e05f/pharmaceutics-14-02659-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffd/9782027/5ef74fc8c537/pharmaceutics-14-02659-g007.jpg

相似文献

1
Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus.使用生物类似物黏液优化用于黏液渗透和纳米颗粒区分的高通量模型
Pharmaceutics. 2022 Nov 30;14(12):2659. doi: 10.3390/pharmaceutics14122659.
2
A membrane-free microfluidic approach to mucus permeation for efficient differentiation of mucoadhesive and mucopermeating nanoparticulate systems.无膜微流控方法用于穿透黏液,以有效区分具有黏膜黏附性和黏膜渗透能力的纳米颗粒系统。
Drug Deliv Transl Res. 2023 Apr;13(4):1088-1101. doi: 10.1007/s13346-022-01274-8. Epub 2022 Dec 15.
3
Physical and barrier changes in gastrointestinal mucus induced by the permeation enhancer sodium 8-[(2-hydroxybenzoyl)amino]octanoate (SNAC).渗透促进剂 8-[(2-羟基苯甲酰基)氨基]辛酸钠(SNAC)引起的胃肠道黏液的物理和屏障变化。
J Control Release. 2022 Dec;352:163-178. doi: 10.1016/j.jconrel.2022.09.034. Epub 2022 Oct 19.
4
Synthetic mucus barrier arrays as a nanoparticle formulation screening platform.作为纳米颗粒制剂筛选平台的合成黏液屏障阵列
bioRxiv. 2023 Nov 30:2023.11.29.569212. doi: 10.1101/2023.11.29.569212.
5
Synthetic mucus barrier arrays as a nanoparticle formulation screening platform.作为纳米颗粒制剂筛选平台的合成黏液屏障阵列
RSC Pharm. 2024 Apr 18;1(2):218-226. doi: 10.1039/d3pm00057e. eCollection 2024 Jun 18.
6
The effect of nanoparticle permeation on the bulk rheological properties of mucus from the small intestine.纳米颗粒渗透对小肠黏液整体流变学特性的影响。
Eur J Pharm Biopharm. 2015 Oct;96:484-7. doi: 10.1016/j.ejpb.2015.02.029. Epub 2015 Mar 7.
7
Nanoparticle diffusion within intestinal mucus: Three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles.纳米颗粒在肠道黏液中的扩散:三维响应分析剖析聚电解质、聚乙二醇化和病毒颗粒的表面电荷、尺寸及异质性的影响
Eur J Pharm Biopharm. 2015 Nov;97(Pt A):230-8. doi: 10.1016/j.ejpb.2015.01.023. Epub 2015 Feb 4.
8
Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation.通过颗粒扩散和肽渗透阐明肠道黏液的空间位阻和相互作用屏障特性。
Eur J Pharm Biopharm. 2015 Sep;95(Pt A):136-43. doi: 10.1016/j.ejpb.2015.01.014. Epub 2015 Jan 23.
9
Probing the interaction of nanoparticles with mucin for drug delivery applications using dynamic light scattering.利用动态光散射研究纳米颗粒与粘蛋白在药物递送应用中的相互作用。
Eur J Pharm Biopharm. 2015 Nov;97(Pt A):218-22. doi: 10.1016/j.ejpb.2015.05.004. Epub 2015 May 15.
10
Mimicking the Gastrointestinal Mucus Barrier: Laboratory-Based Approaches to Facilitate an Enhanced Understanding of Mucus Permeation.模拟胃肠道黏液屏障:基于实验室的方法促进对黏液渗透的增强理解。
ACS Biomater Sci Eng. 2023 Jun 12;9(6):2819-2837. doi: 10.1021/acsbiomaterials.1c00814. Epub 2021 Nov 16.

引用本文的文献

1
Optimized Artificial Colonic Mucus Enabling Physiologically Relevant Diffusion Studies of Drugs, Particles, and Delivery Systems.优化的人工结肠黏液用于药物、颗粒和递送系统的生理相关扩散研究
Mol Pharm. 2025 Jul 7;22(7):4032-4045. doi: 10.1021/acs.molpharmaceut.5c00298. Epub 2025 Jun 10.
2
Unveiling the Potential of Surface Polymerized Drug Nanocrystals in Targeted Delivery.揭示表面聚合药物纳米晶体在靶向递送上的潜力。
ACS Appl Mater Interfaces. 2024 Sep 11;16(36):47124-47136. doi: 10.1021/acsami.4c07669. Epub 2024 Aug 28.

本文引用的文献

1
A membrane-free microfluidic approach to mucus permeation for efficient differentiation of mucoadhesive and mucopermeating nanoparticulate systems.无膜微流控方法用于穿透黏液,以有效区分具有黏膜黏附性和黏膜渗透能力的纳米颗粒系统。
Drug Deliv Transl Res. 2023 Apr;13(4):1088-1101. doi: 10.1007/s13346-022-01274-8. Epub 2022 Dec 15.
2
Mimicking the Gastrointestinal Mucus Barrier: Laboratory-Based Approaches to Facilitate an Enhanced Understanding of Mucus Permeation.模拟胃肠道黏液屏障:基于实验室的方法促进对黏液渗透的增强理解。
ACS Biomater Sci Eng. 2023 Jun 12;9(6):2819-2837. doi: 10.1021/acsbiomaterials.1c00814. Epub 2021 Nov 16.
3
Nanoparticles in the clinic: An update post COVID-19 vaccines.
临床中的纳米颗粒:新冠疫苗后的最新情况
Bioeng Transl Med. 2021 Aug 13;6(3):e10246. doi: 10.1002/btm2.10246. eCollection 2021 Sep.
4
In Vitro Reconstitution of an Intestinal Mucus Layer Shows That Cations and pH Control the Pore Structure That Regulates Its Permeability and Barrier Function.肠道黏液层的体外重建表明,阳离子和pH值控制着调节其通透性和屏障功能的孔隙结构。
ACS Appl Bio Mater. 2020 May 18;3(5):2897-2909. doi: 10.1021/acsabm.9b00851. Epub 2020 Jan 29.
5
Comparing the permeability of human and porcine small intestinal mucus for particle transport studies.比较人源和猪源小肠黏液对颗粒传递研究的通透性。
Sci Rep. 2020 Nov 20;10(1):20290. doi: 10.1038/s41598-020-77129-4.
6
Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies.肠道黏膜防御与炎症中的黏蛋白:从临床和实验研究中学习
Front Immunol. 2020 Sep 4;11:2054. doi: 10.3389/fimmu.2020.02054. eCollection 2020.
7
A Comparison of Chitosan, Mesoporous Silica and Poly(lactic-co-glycolic) Acid Nanocarriers for Optimising Intestinal Uptake of Oral Protein Therapeutics.壳聚糖、介孔硅和聚(乳酸-共-乙醇酸)纳米载体在优化口服蛋白治疗剂肠道吸收方面的比较。
J Pharm Sci. 2021 Jan;110(1):217-227. doi: 10.1016/j.xphs.2020.09.026. Epub 2020 Sep 24.
8
Mucus barrier, mucins and gut microbiota: the expected slimy partners?黏液屏障、黏蛋白和肠道微生物群:理想的黏糊搭档?
Gut. 2020 Dec;69(12):2232-2243. doi: 10.1136/gutjnl-2020-322260. Epub 2020 Sep 11.
9
Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown.人类肠道微生物群中的突出成员表达内作用的 O-聚糖酶,以启动粘蛋白的分解。
Nat Commun. 2020 Aug 11;11(1):4017. doi: 10.1038/s41467-020-17847-5.
10
Critical considerations in the formulation development of parenteral biologic drugs.在制备注射用生物药物的过程中需要考虑的关键因素。
Drug Discov Today. 2020 Mar;25(3):574-581. doi: 10.1016/j.drudis.2019.12.011. Epub 2020 Jan 8.